Search Results - "Hagl, C."

Refine Results
  1. 1

    Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery by Solomon, C., Hagl, C., Rahe-Meyer, N.

    Published in British journal of anaesthesia : BJA (01-06-2013)
    “…There is currently a contrast between the demonstrated benefits of fibrinogen concentrate in correcting bleeding and reducing transfusion, and its perceived…”
    Get full text
    Journal Article
  2. 2

    Tissue-engineering acellular scaffolds-The significant influence of physical and procedural decellularization factors by Starnecker, F, König, F, Hagl, C, Thierfelder, N

    “…The importance of decellularized medical products has significantly increased during the last years. In this paper, we evaluated the effects of selected…”
    Get full text
    Journal Article
  3. 3

    Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery by Solomon, C., Pichlmaier, U., Schoechl, H., Hagl, C., Raymondos, K., Scheinichen, D., Koppert, W., Rahe-Meyer, N.

    Published in British journal of anaesthesia : BJA (01-05-2010)
    “…Normalization of plasma fibrinogen levels may be associated with satisfactory haemostasis and reduced bleeding. The aim of this retrospective study was to…”
    Get full text
    Journal Article
  4. 4

    Pericardial tissue for cardiovascular application: an in-vitro evaluation of established and advanced production processes by Grefen, L., König, F., Grab, M., Hagl, C., Thierfelder, N.

    “…Pericardial tissue is widely used as a biomaterial, especially for cardiovascular application. Tissue processing plays a key role in developing future…”
    Get full text
    Journal Article
  5. 5

    Introduction of the Lung Allocation Score in Germany by Gottlieb, J., Greer, M., Sommerwerck, U., Deuse, T., Witt, C., Schramm, R., Hagl, C., Strueber, M., Smits, J. M.

    Published in American journal of transplantation (01-06-2014)
    “…The aim of this study was to assess performance of the new lung allocation system in Germany based on lung allocation score (LAS). Retrospective analysis of…”
    Get full text
    Journal Article
  6. 6

    Lung transplantation: current situation and developments by Michel, S G, Hagl, C, Kauke, T, Kneidinger, N, Schneider, C

    Published in Chirurgie (Heidelberg, Germany) (01-02-2024)
    “…Lung transplantation is currently the gold standard treatment for end-stage lung diseases. Advances in the preservation of donor lungs, the surgical technique…”
    Get more information
    Journal Article
  7. 7

    Rapid Activation of Pro-Lymphangiogenic Phenotype and Consequent Increase of Lymphatic Density Occurs during the Development of Chronic Lung Allograft Dysfunction by Liu, H., Zistler, K., Jeridi, A., Morrone, C., Schulte-Döinghaus, S., Hagl, C., Yildirim, A., Michel, S., Dashkevich, A.

    “…Lung transplant shows poor long-term survival due to chronic lung allograft dysfunction (CLAD). VEGF-C/VEGFR3 signaling may regulate lymphatic vessel…”
    Get full text
    Journal Article
  8. 8

    Patient transport and networks for use of extracorporeal life support by Born, F, Müller, C, Hanuna, M, Boeken, U, Hagl, C

    “…New technologies and continuous further development of extracorporeal support systems have expanded the range of applications of extracorporeal life support…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Ventricular assist device therapy and heart transplantation: Benefits, drawbacks, and outlook by Buchholz, S., Guenther, S. P. W., Michel, S., Schramm, R., Hagl, C.

    Published in Herz (01-08-2018)
    “…End-stage heart failure is associated with significant morbidity and mortality. Heart transplantation has the potential to offer a return to daily activities…”
    Get full text
    Journal Article
  11. 11

    Indications and strategies in mechanical circulatory support : Rise of the machines? by Dashkevich, A, Michel, S, Hagl, C

    “…Terminal heart failure is an emerging problem with a continuously growing number of diseased patients worldwide. Because of the limited number of donor hearts,…”
    Get full text
    Journal Article
  12. 12

    Association between students' personality traits and hand hygiene compliance during objective standardized clinical examinations by Schüttpelz-Brauns, K, Obertacke, U, Kaden, J, Hagl, C.I

    Published in The Journal of hospital infection (01-03-2015)
    “…Summary Background Although the need for hand hygiene (HH) is generally accepted, studies continue to document inadequate compliance. Medical students are…”
    Get full text
    Journal Article
  13. 13

    Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery by Solomon, C., Budde, U., Schneppenheim, S., Czaja, E., Hagl, C., Schoechl, H., von Depka, M., Rahe-Meyer, N.

    Published in British journal of anaesthesia : BJA (01-04-2011)
    “…Aortic valve (AV) defects can destroy high molecular weight multimers (HMWM) of von Willebrand factor (VWF), leading to acquired von Willebrand syndrome (aVWS)…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Established interventions for mitral valve regurgitation: Current evidence by Orban, Mathias, Braun, D., Orban, Martin, Gross, L., Näbauer, M., Hagl, C.M., Massberg, S., Hausleiter, J.

    Published in Herz (01-02-2016)
    “…Severe mitral regurgitation (MR) is a growing medical challenge in today’s aging population, leading to increased health expenditure due to the resultant…”
    Get full text
    Journal Article
  16. 16

    Endocrine stress response and inflammatory activation during CABG surgery. A randomized trial comparing remifentanil infusion to intermittent fentanyl by Winterhalter, M., Brandl, K., Rahe-Meyer, N., Osthaus, A., Hecker, H., Hagl, C., Adams, H. A., Piepenbrock, S.

    Published in European journal of anaesthesiology (01-04-2008)
    “…BACKGROUND AND OBJECTIVE:Our aim was to compare a continuous infusion of remifentanil with intermittent boluses of fentanyl as regards the perioperative…”
    Get full text
    Journal Article
  17. 17

    Transient severe tricuspid regurgitation after transplantation of an extremely oversized donor heart in a child—Does size matter? A case report by Birnbaum, J., Ulrich, S. M., Schramm, R., Hagl, C., Lehner, A., Fischer, M., Haas, N. A., Heineking, B.

    Published in Pediatric transplantation (01-02-2017)
    “…In pediatric heart transplantation, the size of the donor organ is an important criterion for organ allocation. Oversized donor hearts are often accepted with…”
    Get full text
    Journal Article
  18. 18
  19. 19

    A single German center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list by Hübner, T., Nickel, T., Steinbeck, G., Massberg, S., Schramm, R., Reichart, B., Hagl, C., Kiwi, A., Weis, Michael

    Published in Clinical research in cardiology (01-11-2015)
    “…Aim Currently, more than 900 patients with end-stage heart failure are listed for heart transplantation in Germany. All patients on the Eurotransplant…”
    Get full text
    Journal Article
  20. 20